Sanni Lahdenperä

6.2k total citations
28 papers, 1.7k citations indexed

About

Sanni Lahdenperä is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sanni Lahdenperä has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sanni Lahdenperä's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (7 papers). Sanni Lahdenperä is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Lipoproteins and Cardiovascular Health (8 papers) and Lipid metabolism and disorders (7 papers). Sanni Lahdenperä collaborates with scholars based in Finland, United Kingdom and United States. Sanni Lahdenperä's co-authors include Marja‐Riitta Taskinen, Mikko Syvänne, Sari Mäkimattila, Hannele Yki‐Järvinen, Ming‐Lin Liu, Robert Bergholm, H Yki-Järvinen, Juhani Kahri, Marju Tilly-Kiesi and Markku Vähätalo and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Sanni Lahdenperä

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanni Lahdenperä Finland 23 1.1k 554 450 266 244 28 1.7k
Ernst J. Schaefer United States 19 540 0.5× 570 1.0× 203 0.5× 253 1.0× 171 0.7× 22 1.2k
Anders Gustafson Sweden 21 671 0.6× 485 0.9× 256 0.6× 305 1.1× 90 0.4× 48 1.7k
R. S. Elkeles United Kingdom 23 881 0.8× 589 1.1× 481 1.1× 503 1.9× 194 0.8× 72 1.9k
Dorothy Bedford United Kingdom 22 1.2k 1.1× 875 1.6× 594 1.3× 342 1.3× 89 0.4× 35 2.0k
Graziana Lupattelli Italy 22 346 0.3× 464 0.8× 558 1.2× 218 0.8× 37 0.2× 80 1.5k
P.-J. Guillausseau France 15 676 0.6× 351 0.6× 109 0.2× 237 0.9× 92 0.4× 21 1.5k
L. A. Carlson Sweden 18 502 0.5× 433 0.8× 299 0.7× 220 0.8× 51 0.2× 33 1.3k
Susan Slagle United States 9 412 0.4× 247 0.4× 239 0.5× 125 0.5× 81 0.3× 13 1.4k
Nobutaka Hirai Japan 17 411 0.4× 227 0.4× 895 2.0× 186 0.7× 66 0.3× 28 1.6k
John R. Erbey United States 12 1.2k 1.1× 594 1.1× 589 1.3× 290 1.1× 339 1.4× 16 2.0k

Countries citing papers authored by Sanni Lahdenperä

Since Specialization
Citations

This map shows the geographic impact of Sanni Lahdenperä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanni Lahdenperä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanni Lahdenperä more than expected).

Fields of papers citing papers by Sanni Lahdenperä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanni Lahdenperä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanni Lahdenperä. The network helps show where Sanni Lahdenperä may publish in the future.

Co-authorship network of co-authors of Sanni Lahdenperä

This figure shows the co-authorship network connecting the top 25 collaborators of Sanni Lahdenperä. A scholar is included among the top collaborators of Sanni Lahdenperä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanni Lahdenperä. Sanni Lahdenperä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verkkoniemi‐Ahola, Auli, Päivi Hartikainen, Hanna Kuusisto, et al.. (2023). Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(4). 3100567666–3100567666. 1 indexed citations
2.
Yki‐Järvinen, Hannele, Leena Juurinen, Michael Alvarsson, et al.. (2007). Initiate Insulin by Aggressive Titration and Education (INITIATE). Diabetes Care. 30(6). 1364–1369. 117 indexed citations
3.
Yki-Järvinen, H, Ronald C.W., Mirja Tiikkainen, et al.. (2006). Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 49(3). 442–451. 329 indexed citations
4.
Vakkilainen, Juha, Päivi Pajukanta, Rita M. Cantor, et al.. (2002). Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia. European Journal of Human Genetics. 10(9). 547–552. 12 indexed citations
5.
Liu, Ming‐Lin, Kati Ylitalo, Juha Vakkilainen, et al.. (2002). Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes. Annals of Medicine. 34(1). 48–54. 18 indexed citations
6.
Vakkilainen, Juha, Sari Mäkimattila, Anneli Seppälä‐Lindroos, et al.. (2000). Endothelial Dysfunction in Men With Small LDL Particles. Circulation. 102(7). 716–721. 103 indexed citations
7.
Bergholm, Robert, Sari Mäkimattila, Miia Valkonen, et al.. (1999). Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis. 145(2). 341–349. 142 indexed citations
8.
Mäkimattila, Sari, Ming‐Lin Liu, Juha Vakkilainen, et al.. (1999). Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.. Diabetes Care. 22(6). 973–981. 131 indexed citations
9.
Raitakari, Olli T., Olli‐Pekka Pitkänen, Terho Lehtimäki, et al.. (1997). In Vivo Low Density Lipoprotein Oxidation Relates to Coronary Reactivity in Young Men. Journal of the American College of Cardiology. 30(1). 97–102. 82 indexed citations
10.
Nuotio, Ilpo, Päivi Pajukanta, Mikko Syvänne, et al.. (1997). Phenotype expression in familial combined hyperlipidemia. Atherosclerosis. 133(2). 245–253. 53 indexed citations
11.
Antikainen, Marjatta, Mikko Uusi‐Oukari, Sonja Ehnholm, et al.. (1997). Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis. 128(2). 165–174. 29 indexed citations
12.
Antikainen, Marjatta, et al.. (1997). The Asn‐291→Ser and Ser‐477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia. European Journal of Clinical Investigation. 27(11). 928–935. 23 indexed citations
13.
14.
Taskinen, Marja‐Riitta, Sanni Lahdenperä, & Mikko Syvänne. (1996). New Insights into Lipid Metabolism in Non-insulin-dependent Diabetes Mellitus. Annals of Medicine. 28(4). 335–340. 42 indexed citations
15.
Lahdenperä, Sanni, Jukka Puolakka, T Pýörälä, H. Luotola, & Marja‐Riitta Taskinen. (1996). Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. Atherosclerosis. 122(2). 153–162. 28 indexed citations
16.
Lahdenperä, Sanni, et al.. (1995). LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis. 113(2). 227–236. 36 indexed citations
17.
Lahdenperä, Sanni, Mikko Syvänne, Juhani Kahri, & Marja‐Riitta Taskinen. (1995). Properties of LDL particles in NIDDM men: Relation to CAD. Atherosclerosis. 115. S22–S22. 1 indexed citations
18.
Välimäki, Matti, Juhani Kahri, Kalevi Laitinen, et al.. (1993). High density lipoprotein subfractions, apolipoprotein A‐I containing lipoproteins, lipoprotein (a), and cholesteryl ester transfer protein activity in alcoholic women before and after ethanol withdrawal. European Journal of Clinical Investigation. 23(7). 406–417. 40 indexed citations
19.
Kahri, Juhani, H. Vuorinen-Markkola, Marju Tilly-Kiesi, Sanni Lahdenperä, & Marja‐Riitta Taskinen. (1993). Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity. Atherosclerosis. 102(1). 79–89. 26 indexed citations
20.
Tilly-Kiesi, Marju, Mikko Syvänne, T Kuusi, Sanni Lahdenperä, & Marja‐Riitta Taskinen. (1992). Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.. Journal of Lipid Research. 33(3). 333–342. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernst J. Schaefer Breakdown of academic impact, for papers by Anders Gustafson Breakdown of academic impact, for papers by R. S. Elkeles Breakdown of academic impact, for papers by Dorothy Bedford Breakdown of academic impact, for papers by Graziana Lupattelli Breakdown of academic impact, for papers by P.-J. Guillausseau Breakdown of academic impact, for papers by L. A. Carlson Breakdown of academic impact, for papers by Susan Slagle Breakdown of academic impact, for papers by Nobutaka Hirai Breakdown of academic impact, for papers by John R. Erbey
Rankless by CCL
2026